−0.990HKD
−418.61 MHKD
113.67 MHKD
382.36 M
About CANBRIDGE PHARMACEUTICALS INC
Sector
CEO
James Xue
Headquarters
Beijing
Website
Employees (FY)
100
Founded
2012
ISIN
KYG1821D1097
FIGI
BBG013TKDNH3
CANbridge Pharmaceuticals Inc. operates as a rare disease-focused biopharmaceutical company committed to the research, development and commercialization of transformative therapies. The firm's pipeline and products include rare oncology, rare diseases, gene theraphy, Huntercase, Nerlynx, and Caphosol. It operates through the following geographical segment: Mainland China, Taiwan, and Hong Kong. The company was founded by James Xue in 2012 and is headquartered in Beijing, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 1228 is 0.320 HKD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange CANBRIDGE PHARMACEUTICALS INC stocks are traded under the ticker 1228.
CANBRIDGE PHARMACEUTICALS INC is going to release the next earnings report on Aug 21, 2024. Keep track of upcoming events with our Earnings Calendar.
1228 stock is 1.59% volatile and has beta coefficient of 0.42. Check out the list of the most volatile stocks — is CANBRIDGE PHARMACEUTICALS INC there?
Yes, you can track CANBRIDGE PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
1228 stock has risen by 4.92% compared to the previous week, the last month showed zero change in price, over the last year CANBRIDGE PHARMACEUTICALS INC has showed a 83.92% decrease.
1228 net income for the last quarter is −173.58 M HKD, while the quarter before that showed −246.73 M HKD of net income which accounts for 29.65% change. Track more CANBRIDGE PHARMACEUTICALS INC financial stats to get the full picture.
No, 1228 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 1228 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CANBRIDGE PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 100.00 employees. See our rating of the largest employees — is CANBRIDGE PHARMACEUTICALS INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CANBRIDGE PHARMACEUTICALS INC technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CANBRIDGE PHARMACEUTICALS INC stock shows the neutral signal. See more of CANBRIDGE PHARMACEUTICALS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CANBRIDGE PHARMACEUTICALS INC EBITDA is −384.27 M HKD, and current EBITDA margin is −343.90%. See more stats in CANBRIDGE PHARMACEUTICALS INC financial statements.